Evaluation of high-dose aspirin elimination in the treatment of Kawasaki disease in the incidence of coronary artery aneurysm
Background: Standard first-step therapy for Kawasaki disease consists of Intravenous immunoglobulin and high dose Aspirin (80-100 mg/kg/day). The standard dose of Intravenous immunoglobulin (2gr/kg) is strongly effective in reducing the risk of coronary arteries abnormalities. So, the proper dose an...
Saved in:
Main Authors: | Farima Sanati (Author), Mohammadmehdi Bagheri (Author), Shahryar Eslami (Author), Ali Khalooei (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Coronary artery aneurysm in kawasaki disease
by: Achala Donuru, et al.
Published: (2020) -
Predictive risk factors of coronary artery aneurysms in Kawasaki disease
by: Hyang-Ok Woo
Published: (2019) -
Cyclophosphamide use in treatment of refractory Kawasaki disease with coronary artery aneurysms
by: Olha Halyabar, et al.
Published: (2021) -
Prediction nomogram for coronary artery aneurysms at one month in Kawasaki disease
by: Yunjia Tang, et al.
Published: (2023) -
Giant coronary artery aneurysm with a thrombus secondary to Kawasaki disease
by: Patil Sushant, et al.
Published: (2008)